Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-26 @ 6:13 PM
Study NCT ID:
NCT01973218
Status:
COMPLETED
Last Update Posted:
2015-10-30
First Post:
2013-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.
Sponsor:
Novartis Vaccines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-25
First Submit QC Date:
None
Study First Post Date:
2013-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-20
Results First Submit QC Date:
None
Results First Post Date:
2015-03-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-05
Last Update Post Date:
2015-10-30
Last Update Post Date Type:
ESTIMATED